Nanoporous Peptide Particles for Encapsulating and Releasing Neurotrophic Factors in an Animal Model of Neurodegeneration

Neurotrophin‐BDNF can be effectively encapsulated in nanoporous poly(L‐glutamic acid) particles prepared via mesoporous silica templating. The loaded BDNF can be released in a sustained manner with retained biological activity. Animal experiments demonstrate the released BDNF can efficiently rescue...

Full description

Saved in:
Bibliographic Details
Published inAdvanced materials (Weinheim) Vol. 24; no. 25; pp. 3362 - 3366
Main Authors Tan, Justin, Wang, Yajun, Yip, Xiaopei, Glynn, Fergal, Shepherd, Robert K., Caruso, Frank
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 03.07.2012
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Neurotrophin‐BDNF can be effectively encapsulated in nanoporous poly(L‐glutamic acid) particles prepared via mesoporous silica templating. The loaded BDNF can be released in a sustained manner with retained biological activity. Animal experiments demonstrate the released BDNF can efficiently rescue the auditory neurons (as indicated by the arrows) in the cochlea of guinea pigs with sensorineural hearing loss.
AbstractList Neurotrophin-BDNF can be effectively encapsulated in nanoporous poly(L-glutamic acid) particles prepared via mesoporous silica templating. The loaded BDNF can be released in a sustained manner with retained biological activity. Animal experiments demonstrate the released BDNF can efficiently rescue the auditory neurons (as indicated by the arrows) in the cochlea of guinea pigs with sensorineural hearing loss.
Neurotrophin-BDNF can be effectively encapsulated in nanoporous poly(L-glutamic acid) particles prepared via mesoporous silica templating. The loaded BDNF can be released in a sustained manner with maintained biological activity. Animal experiments demonstrate the released BDNF can efficiently rescue the auditory neurons (as indicated by the arrows) in the cochlea of guinea pigs with sensorineural hearing loss.
Neurotrophin-BDNF can be effectively encapsulated in nanoporous poly(L-glutamic acid) particles prepared via mesoporous silica templating. The loaded BDNF can be released in a sustained manner with retained biological activity. Animal experiments demonstrate the released BDNF can efficiently rescue the auditory neurons (as indicated by the arrows) in the cochlea of guinea pigs with sensorineural hearing loss.Neurotrophin-BDNF can be effectively encapsulated in nanoporous poly(L-glutamic acid) particles prepared via mesoporous silica templating. The loaded BDNF can be released in a sustained manner with retained biological activity. Animal experiments demonstrate the released BDNF can efficiently rescue the auditory neurons (as indicated by the arrows) in the cochlea of guinea pigs with sensorineural hearing loss.
Author Tan, Justin
Wang, Yajun
Shepherd, Robert K.
Glynn, Fergal
Caruso, Frank
Yip, Xiaopei
Author_xml – sequence: 1
  givenname: Justin
  surname: Tan
  fullname: Tan, Justin
  organization: Bionics Institute, East Melbourne, Victoria 3002, Australia
– sequence: 2
  givenname: Yajun
  surname: Wang
  fullname: Wang, Yajun
  organization: Department of Chemical and Biomolecular Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia
– sequence: 3
  givenname: Xiaopei
  surname: Yip
  fullname: Yip, Xiaopei
  organization: Bionics Institute, East Melbourne, Victoria 3002, Australia
– sequence: 4
  givenname: Fergal
  surname: Glynn
  fullname: Glynn, Fergal
  organization: Bionics Institute, East Melbourne, Victoria 3002, Australia
– sequence: 5
  givenname: Robert K.
  surname: Shepherd
  fullname: Shepherd, Robert K.
  organization: Bionics Institute, East Melbourne, Victoria 3002, Australia
– sequence: 6
  givenname: Frank
  surname: Caruso
  fullname: Caruso, Frank
  email: fcaruso@unimelb.edu.au
  organization: Department of Chemical and Biomolecular Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22610659$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1v0zAYhy00xLrBlSPykUuK7cROfEGqug9AWxkdH0fLcd50htTO7ATof4-rjGqcOFm2n9_jV_6doCPnHSD0kpI5JYS90c1WzxmhjBCRF0_QjHJGs4JIfoRmROY8k6KojtFJjN8JIVIQ8QwdMyYoEVzO0G6lne998GPEN9APtgF8o8NgTQcRtz7gc2d0H8dOD9ZtsHYNXkMHOu53KxiDH4Lv76zBF9oMPkRsXaLwwtmt7vC1b6DDvp3QBjbgICSVd8_R01Z3EV48rKfoy8X55-W77Orj5fvl4ioznPIiq7SuamEqLTRviATTCJmWsmw5pUwWwrSlFJWpSTqRBLiumcgNq2vJNK14foreTt5-rLfQGHBD0J3qQ5ov7JTXVv174-yd2vifKudFnvJJ8PpBEPz9CHFQWxsNdJ12kL5NUcIY41JWIqHzCTXBxxigPTxDidr3pfZ9qUNfKfDq8XAH_G9BCZAT8Mt2sPuPTi3OrheP5dmUtXGA34esDj-UKPOSq2-rS3W7Plt_-nC7VF_zP8brti8
CitedBy_id crossref_primary_10_1007_s12017_015_8369_3
crossref_primary_10_1002_anie_201303055
crossref_primary_10_1088_1741_2560_9_6_065002
crossref_primary_10_3390_polym8060214
crossref_primary_10_1371_journal_pone_0194778
crossref_primary_10_1021_acs_chemmater_6b02848
crossref_primary_10_1039_C2TB00344A
crossref_primary_10_1016_j_ijpharm_2016_11_021
crossref_primary_10_1021_acsami_8b10415
crossref_primary_10_1039_c3ta01444d
crossref_primary_10_1186_1556_276X_9_343
crossref_primary_10_3389_fncel_2021_682597
crossref_primary_10_3390_pharmaceutics15020442
crossref_primary_10_1021_nn404481f
crossref_primary_10_1039_c3nj00480e
crossref_primary_10_1021_acs_langmuir_6b00717
crossref_primary_10_1038_srep04733
crossref_primary_10_1021_acs_chemmater_9b01530
crossref_primary_10_1021_la402146t
crossref_primary_10_1002_adhm_201500141
crossref_primary_10_1002_cne_23318
crossref_primary_10_1177_2041731418808455
crossref_primary_10_1007_s11095_013_1037_0
crossref_primary_10_1002_adfm_202107074
crossref_primary_10_1016_j_mtbio_2020_100055
crossref_primary_10_1002_adma_201300981
crossref_primary_10_2217_nnm_13_104
crossref_primary_10_1016_j_cis_2020_102334
crossref_primary_10_1002_adfm_201703982
crossref_primary_10_1371_journal_pone_0164867
crossref_primary_10_1002_mba2_47
crossref_primary_10_1021_jacs_8b01641
crossref_primary_10_1155_2017_3098230
crossref_primary_10_1002_anie_201710272
crossref_primary_10_1016_j_ijbiomac_2024_130726
crossref_primary_10_1021_acschemneuro_8b00700
crossref_primary_10_2217_nnm_2019_0114
crossref_primary_10_1007_s12640_016_9689_2
crossref_primary_10_3390_pharmaceutics15092236
crossref_primary_10_1016_j_cis_2013_11_011
crossref_primary_10_1039_D4BM00518J
crossref_primary_10_1002_smll_201401767
crossref_primary_10_1002_ange_201303055
crossref_primary_10_3390_md18020082
crossref_primary_10_1016_j_jcis_2021_02_098
crossref_primary_10_1021_nn401800u
crossref_primary_10_3390_pharmaceutics5010127
crossref_primary_10_1007_s10162_023_00904_3
crossref_primary_10_3390_nano10061075
crossref_primary_10_1021_la501324r
crossref_primary_10_1002_wnan_1696
crossref_primary_10_1016_j_drudis_2013_07_010
crossref_primary_10_1155_2016_9417874
crossref_primary_10_1002_ange_201710272
crossref_primary_10_4103_1673_5374_369096
crossref_primary_10_1016_j_heares_2018_05_002
crossref_primary_10_1016_j_cis_2014_04_001
crossref_primary_10_1186_s13287_020_02090_y
crossref_primary_10_1016_j_jcis_2020_02_106
crossref_primary_10_1016_j_pharmthera_2019_05_003
crossref_primary_10_3390_medicina58060747
crossref_primary_10_1002_pat_3406
crossref_primary_10_1016_j_jconrel_2015_03_024
crossref_primary_10_3389_fbioe_2022_776890
Cites_doi 10.1016/j.biomaterials.2009.11.032
10.1002/cne.20564
10.2353/ajpath.2006.060122
10.1080/10611860701231810
10.1146/annurev.neuro.22.1.295
10.1016/0166-2236(91)90097-E
10.1159/000046130
10.1016/S0896-6273(00)80853-3
10.1002/adma.201101609
10.1038/sj.clpt.6100400
10.1046/j.1471-4159.1999.0731409.x
10.1146/annurev.ne.19.030196.001445
10.1016/S0301-0082(00)00014-9
10.1002/anie.200462135
10.1016/j.ijpharm.2010.02.003
10.1038/nm.1912
10.1371/journal.pone.0018733
10.1002/adma.200501901
10.1146/annurev.neuro.25.112701.142849
10.1039/b901742a
10.1021/cm901621y
10.1021/ma071125s
10.1016/j.addr.2006.09.011
10.1002/jbm.10110
10.1159/000013861
10.1021/nl080877c
10.1080/07388550802107483
10.1046/j.1471-4159.2000.0750991.x
10.1016/j.biomaterials.2004.02.057
10.1021/bm1005799
10.1007/s11095-006-9039-9
10.1073/pnas.251543398
10.1002/adma.201001497
ContentType Journal Article
Copyright Copyright © 2012 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Copyright_xml – notice: Copyright © 2012 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
– notice: Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1002/adma.201200634
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1521-4095
EndPage 3366
ExternalDocumentID 10_1002_adma_201200634
22610659
ADMA201200634
ark_67375_WNG_SRDRQJSC_V
Genre shortCommunication
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: OLAO NIH HHS
  grantid: HHSN263200700053C
– fundername: National Institute on Deafness and Other Communication Disorders : NIDCD
  grantid: HHSN263200700053C || DC
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23M
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
EBS
EJD
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
Q.N
Q11
QB0
QRW
R.K
RNS
ROL
RWI
RWM
RX1
RYL
SUPJJ
TN5
UB1
UPT
V2E
W8V
W99
WBKPD
WFSAM
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
XPP
XV2
YR2
ZZTAW
~02
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c5154-8aa8b6c8a6a5d09ecd6909e77f5112946cf7968cb07f590e5ab263c2bb92a1853
IEDL.DBID DR2
ISSN 0935-9648
1521-4095
IngestDate Tue Sep 17 21:17:43 EDT 2024
Sat Oct 26 04:56:37 EDT 2024
Fri Aug 23 03:19:57 EDT 2024
Sat Nov 02 12:29:26 EDT 2024
Sat Aug 24 01:12:41 EDT 2024
Wed Oct 30 09:49:50 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 25
Language English
License Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5154-8aa8b6c8a6a5d09ecd6909e77f5112946cf7968cb07f590e5ab263c2bb92a1853
Notes istex:6E8528585892DFEA5A63C75196CC94697FBC3F43
ark:/67375/WNG-SRDRQJSC-V
ArticleID:ADMA201200634
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
J. Tan and Y. Wang contributed equally.
OpenAccessLink https://europepmc.org/articles/pmc3543853?pdf=render
PMID 22610659
PQID 1022259986
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3543853
proquest_miscellaneous_1022259986
crossref_primary_10_1002_adma_201200634
pubmed_primary_22610659
wiley_primary_10_1002_adma_201200634_ADMA201200634
istex_primary_ark_67375_WNG_SRDRQJSC_V
PublicationCentury 2000
PublicationDate July 3, 2012
PublicationDateYYYYMMDD 2012-07-03
PublicationDate_xml – month: 07
  year: 2012
  text: July 3, 2012
  day: 03
PublicationDecade 2010
PublicationPlace Weinheim
PublicationPlace_xml – name: Weinheim
– name: Germany
PublicationTitle Advanced materials (Weinheim)
PublicationTitleAlternate Adv. Mater
PublicationYear 2012
Publisher WILEY-VCH Verlag
WILEY‐VCH Verlag
Publisher_xml – name: WILEY-VCH Verlag
– name: WILEY‐VCH Verlag
References a) Y. Wang, F. Caruso, Adv. Mater. 2006, 18, 795
a) A. K. McAllister, L. C. Katz, D. C. Lo, Annu. Rev. Neurosci. 1999, 22, 295
b) L. N. Pettingill, A. K. Wise, M. S. Geaney, R. K. Shepherd, PLoS One 2011, 6, e18733
e) Y. Wang, Y. Yan, J. W. Cui, L. Hosta-Rigau, J. K. Heath, E. C. Nice, F. Caruso, Adv. Mater. 2010, 22, 4293.
b) D. F. Emerich, C. G. Thanos, J. Drug Target. 2007, 15, 163
f) Y. Yan, Y. Wang, J. K. Heath, E. C. Nice, F. Caruso, Adv. Mater. 2011, 23, 3916.
b) Y. Wang, A. S. Angelatos, D. E. Dunstan, F. Caruso, Macromolecules 2007, 40, 7594
a) O. C. Farokhzad, R. Langer, Adv. Drug Deliv. Rev. 2006, 58, 1456
b) L. Minichiello, M. Korte, D. Wolfer, R. Kuhn, K. Unsicker, V. Cestari, C. Rossi-Arnaud, H. P. Lipp, T. Bonhoeffer, R. Klein, Neuron 1999, 24, 401
a) H. J. Chung, H. K. Kim, J. J. Yoon, T. G. Park, Pharm. Res. 2006, 23, 1835
b) J. Tan, R. K. Shepherd, Am. J. Pathol. 2006, 169, 528.
b) P. Tryoen-Toth, D. Vautier, Y. Haikel, J. C. Voegel, P. Schaaf, J. Chluba, J. Ogier, J. Biomedical Mater. Res. 2002, 60, 657.
c) M. Praetorius, A. Limberger, M. Muller, R. Lehner, B. Schick, H. P. Zenner, P. Plinkert, M. Knipper, Audiol. Neurootol. 2001, 6, 250.
c) L. Zhang, F. X. Gu, J. M. Chan, A. Z. Wang, R. S. Langer, O. C. Farokhzad, Clin. Pharmacol. Ther. 2008, 83, 761
e) X. Zhang, M. Oulad-Abdelghani, C. Mendoza, A. N. Zelkin, Y. Wang, Y. Haîkel, D. Mainard, J.-C. Voegel, F. Caruso, N. Benkirane-Jessel, Biomaterials 2010, 31, 1699
a) T. Hans, Trends Neurosci. 1991, 14, 165
a) Y. Wang, A. M. Yu, F. Caruso, Angew. Chem. Int. Ed. 2005, 44, 2888
b) J. Almodovar, S. Bacon, J. Gogolski, J. D. Kisiday, M. J. Kipper, Biomacromolecules 2010, 11, 2629.
M. Encinas, M. Iglesias, Y. H. Liu, H. Y. Wang, A. Muhaisen, V. Cena, C. Gallego, J. X. Comella, J. Neurochem. 2000, 75, 991.
M. Encinas, M. Iglesias, N. Llecha, J. X. Comella, J. Neurochem. 1999, 73, 1409.
A. Forge, J. Schacht, Audiol. Neurootol. 2000, 5, 3.
C. Vodouhe, M. Schmittbuhl, F. Boulmedais, D. Bagnard, D. Vautier, P. Schaaf, C. Egles, J. C. Voegel, J. Ogier, Biomaterials 2005, 26, 545.
b) G. R. Lewin, Y. A. Barde, Annu. Rev. Neurosci. 1996, 19, 289.
c) Y. Wang, V. Bansal, A. N. Zelikin, F. Caruso, Nano Letters 2008, 8, 1741
a) B. Manocha, A. Margaritis, Crit. Rev. Biotechnol. 2008, 28, 83
c) J. R. Chan, J. M. Cosgaya, Y. J. Wu, E. M. Shooter, Proc. Nat. Acad. Sci. U.S.A. 2001, 98, 14661.
d) J. W. Cui, Y. Wang, J. C. Hao, F. Caruso, Chem. Mater. 2009, 21, 4310
a) M. G. Murer, Q. Yan, R. Raisman-Vozari, Prog. Neurobio. 2001, 63, 71
M. M. Cox, D. L. Nelson, in Lehninger Principles of Biochemistry (Eds: D. L. Nelson, M. M. Cox) Freeman, 2004, p. 1100.
d) S. Roy, A. H. Johnston, T. A. Newman, R. Glueckert, J. Dudas, M. Bitsche, E. Corbacella, G. Rieger, A. Martini, A. Schrott-Fischer, Int. J. Pharm. 2010, 390, 214
b) Y. Wang, A. D. Price, F. Caruso, J. Mater. Chem. 2009, 19, 6451.
a) A. H. Nagahara, D. A. Merrill, G. Coppola, S. Tsukada, B. E. Schroeder, G. M. Shaked, L. Wang, A. Blesch, A. Kim, J. M. Conner, E. Rockenstein, M. V. Chao, E. H. Koo, D. Geschwind, E. Masliah, A. A. Chiba, M. H. Tuszynski, Nat. Med. 2009, 15, 331
R. K. Shepherd, A. Coco, S. B. Epp, J. M. Crook, J. Comp. Neurol. 2005, 486, 145.
E. W. Rubel, B. Fritzsch, Annu. Rev. Neurosci. 2002, 25, 51.
2002; 25
2001 2006; 63 169
2006 2007 2008 2010 2010; 58 15 83 390 22
2000; 5
2006 2007 2008 2009 2010 2011; 18 40 8 21 31 23
2005; 486
2005 2009; 44 19
2008 2002; 28 60
2000; 75
2006 2010; 23 11
1999 1999 2001; 22 24 98
2004
1999; 73
2005; 26
1991 1996; 14 19
2009 2011 2001; 15 6 6
Cox M. M. (e_1_2_5_9_2) 2004
e_1_2_5_7_6
e_1_2_5_14_2
e_1_2_5_7_5
e_1_2_5_13_2
e_1_2_5_5_6
e_1_2_5_7_4
e_1_2_5_8_3
e_1_2_5_16_2
e_1_2_5_5_5
e_1_2_5_7_3
e_1_2_5_8_2
e_1_2_5_15_2
e_1_2_5_5_4
e_1_2_5_6_3
e_1_2_5_7_2
e_1_2_5_10_2
e_1_2_5_4_4
e_1_2_5_5_3
e_1_2_5_6_2
e_1_2_5_4_3
e_1_2_5_5_2
e_1_2_5_12_2
e_1_2_5_2_4
e_1_2_5_3_3
e_1_2_5_4_2
e_1_2_5_10_3
e_1_2_5_11_2
e_1_2_5_2_3
e_1_2_5_3_2
e_1_2_5_1_3
e_1_2_5_2_2
e_1_2_5_1_2
e_1_2_5_7_7
References_xml – start-page: 1100
  year: 2004
– volume: 23 11
  start-page: 1835 2629
  year: 2006 2010
  publication-title: Pharm. Res. Biomacromolecules
– volume: 14 19
  start-page: 165 289
  year: 1991 1996
  publication-title: Trends Neurosci. Annu. Rev. Neurosci.
– volume: 22 24 98
  start-page: 295 401 14661
  year: 1999 1999 2001
  publication-title: Annu. Rev. Neurosci. Neuron Proc. Nat. Acad. Sci. U.S.A.
– volume: 44 19
  start-page: 2888 6451
  year: 2005 2009
  publication-title: Angew. Chem. Int. Ed. J. Mater. Chem.
– volume: 5
  start-page: 3
  year: 2000
  publication-title: Audiol. Neurootol.
– volume: 15 6 6
  start-page: 331 e18733 250
  year: 2009 2011 2001
  publication-title: Nat. Med. PLoS One Audiol. Neurootol.
– volume: 18 40 8 21 31 23
  start-page: 795 7594 1741 4310 1699 3916
  year: 2006 2007 2008 2009 2010 2011
  publication-title: Adv. Mater. Macromolecules Nano Letters Chem. Mater. Biomaterials Adv. Mater.
– volume: 63 169
  start-page: 71 528
  year: 2001 2006
  publication-title: Prog. Neurobio. Am. J. Pathol.
– volume: 58 15 83 390 22
  start-page: 1456 163 761 214 4293
  year: 2006 2007 2008 2010 2010
  publication-title: Adv. Drug Deliv. Rev. J. Drug Target. Clin. Pharmacol. Ther. Int. J. Pharm. Adv. Mater.
– volume: 28 60
  start-page: 83 657
  year: 2008 2002
  publication-title: Crit. Rev. Biotechnol. J. Biomedical Mater. Res.
– volume: 486
  start-page: 145
  year: 2005
  publication-title: J. Comp. Neurol.
– volume: 75
  start-page: 991
  year: 2000
  publication-title: J. Neurochem.
– volume: 26
  start-page: 545
  year: 2005
  publication-title: Biomaterials
– volume: 73
  start-page: 1409
  year: 1999
  publication-title: J. Neurochem.
– volume: 25
  start-page: 51
  year: 2002
  publication-title: Annu. Rev. Neurosci.
– ident: e_1_2_5_7_6
  doi: 10.1016/j.biomaterials.2009.11.032
– ident: e_1_2_5_14_2
  doi: 10.1002/cne.20564
– ident: e_1_2_5_3_3
  doi: 10.2353/ajpath.2006.060122
– ident: e_1_2_5_5_3
  doi: 10.1080/10611860701231810
– ident: e_1_2_5_2_2
  doi: 10.1146/annurev.neuro.22.1.295
– ident: e_1_2_5_1_2
  doi: 10.1016/0166-2236(91)90097-E
– ident: e_1_2_5_4_4
  doi: 10.1159/000046130
– ident: e_1_2_5_2_3
  doi: 10.1016/S0896-6273(00)80853-3
– ident: e_1_2_5_7_7
  doi: 10.1002/adma.201101609
– ident: e_1_2_5_5_4
  doi: 10.1038/sj.clpt.6100400
– ident: e_1_2_5_12_2
  doi: 10.1046/j.1471-4159.1999.0731409.x
– ident: e_1_2_5_1_3
  doi: 10.1146/annurev.ne.19.030196.001445
– ident: e_1_2_5_3_2
  doi: 10.1016/S0301-0082(00)00014-9
– ident: e_1_2_5_6_2
  doi: 10.1002/anie.200462135
– ident: e_1_2_5_5_5
  doi: 10.1016/j.ijpharm.2010.02.003
– ident: e_1_2_5_4_2
  doi: 10.1038/nm.1912
– ident: e_1_2_5_4_3
  doi: 10.1371/journal.pone.0018733
– ident: e_1_2_5_7_2
  doi: 10.1002/adma.200501901
– ident: e_1_2_5_16_2
  doi: 10.1146/annurev.neuro.25.112701.142849
– ident: e_1_2_5_6_3
  doi: 10.1039/b901742a
– start-page: 1100
  volume-title: Lehninger Principles of Biochemistry
  year: 2004
  ident: e_1_2_5_9_2
  contributor:
    fullname: Cox M. M.
– ident: e_1_2_5_7_5
  doi: 10.1021/cm901621y
– ident: e_1_2_5_7_3
  doi: 10.1021/ma071125s
– ident: e_1_2_5_5_2
  doi: 10.1016/j.addr.2006.09.011
– ident: e_1_2_5_8_3
  doi: 10.1002/jbm.10110
– ident: e_1_2_5_15_2
  doi: 10.1159/000013861
– ident: e_1_2_5_7_4
  doi: 10.1021/nl080877c
– ident: e_1_2_5_8_2
  doi: 10.1080/07388550802107483
– ident: e_1_2_5_11_2
  doi: 10.1046/j.1471-4159.2000.0750991.x
– ident: e_1_2_5_13_2
  doi: 10.1016/j.biomaterials.2004.02.057
– ident: e_1_2_5_10_3
  doi: 10.1021/bm1005799
– ident: e_1_2_5_10_2
  doi: 10.1007/s11095-006-9039-9
– ident: e_1_2_5_2_4
  doi: 10.1073/pnas.251543398
– ident: e_1_2_5_5_6
  doi: 10.1002/adma.201001497
SSID ssj0009606
Score 2.3996284
Snippet Neurotrophin‐BDNF can be effectively encapsulated in nanoporous poly(L‐glutamic acid) particles prepared via mesoporous silica templating. The loaded BDNF can...
Neurotrophin-BDNF can be effectively encapsulated in nanoporous poly(L-glutamic acid) particles prepared via mesoporous silica templating. The loaded BDNF can...
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 3362
SubjectTerms Animals
Apoptosis - drug effects
Brain-Derived Neurotrophic Factor - administration & dosage
Brain-Derived Neurotrophic Factor - chemistry
Brain-Derived Neurotrophic Factor - pharmacology
Cell Line, Tumor
Cochlea - metabolism
Disease Models, Animal
Drug Carriers - chemistry
drug delivery
Guinea Pigs
Hearing Loss, Sensorineural - chemically induced
Hearing Loss, Sensorineural - drug therapy
Humans
mesoporous silica
Nanoparticles - chemistry
nanoporous polymer particles
neurotrophic factors
Peptides - chemistry
Porosity
sensorineural hearing loss
Title Nanoporous Peptide Particles for Encapsulating and Releasing Neurotrophic Factors in an Animal Model of Neurodegeneration
URI https://api.istex.fr/ark:/67375/WNG-SRDRQJSC-V/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fadma.201200634
https://www.ncbi.nlm.nih.gov/pubmed/22610659
https://www.proquest.com/docview/1022259986
https://pubmed.ncbi.nlm.nih.gov/PMC3543853
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQucABKM_wqIyE4JQ2aztOclx1u60qtSpbCr1ZY8dpVwWn2u5KwK_HYzfpbkFCglse40Qznom_sSefCXmXa6l9YlWmDec8FQZMCgUrU9BaciHqvAw7zx0cyr0TsX-any79xR_5IfoJN4yM8L3GAAd9tXVDGgp14A0aYE7MkRB0wAus6RpNbvijEJ4Hsj2ep5UUZcfamLGt1eYro9JdNPD3P0HO3ysnlxFtGJLGDwl0ysRKlIvNxVxvmp-3eB7_R9tH5ME1XqXD6GDr5I51j8n9JRbDJ-SH_0K3Hsa3iyt6hEUytaVHXcEd9aCY7jgDPhvHsjt3RsHVdOJHO8BpChrYQeaz9vJ8aug47v5Dp85L0aGbfvPvxu3avtK2iaK1PQtM2ehQT8nJeOfT9l56vaNDajxuEmkJUGppSpCQ11llTe2T88oWRRNwn5CmKSpZGp35K1Vmc9BMcsO0rhggsnhG1lzr7AtCBRLbcF5BYaVoykI32gLPLOMNy-wAEvKh61F1GYk7VKRoZgqNqXpjJuR96PBeDGYXWO5W5OrL4a46nowmH_ePt9XnhLztPEL5IMSVFXDWG1fFtNlnrjIhz6OH9E_z-HaAi9cJKVZ8pxdAgu_VO256Hoi-eS64VzohLLjGX_RQw9HBsD97-S-NXpF7eBzKkflrsjafLewbD7rmeiME1i9jjyXo
link.rule.ids 230,315,783,787,888,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_B9gA88P0RPo2E4ClbGjuO81itK2Ws1eg2xptlO85WDZyptBLw1-NzlmwFJCR4jHNOdPZd_Dv78juAV5nm2gdWIq4opTEzysQqT0WstOaUsTITofLceMJHh2znU9ZmE-K_MA0_RLfhhp4Rvtfo4LghvXnBGqrKQBzUw6CYsquw7n2eYvWGwfSCQQoBeqDbo1lccCZa3sYk3Vztv7IureMQf_sT6Pw9d_Iypg2L0vAW6FadJhfldGO50Bvmxy9Mj_-l7224eQ5ZSb-xsTtwxbq7cOMSkeE9-O4_0rVH8vXyK9nDPJnSkr025454XEy2nVE-IMfMO3dMlCvJ1C94CncqSCAIWczrs5OZIcOmABCZOS9F-m72xb8bK7Z9JnXViJb2OJBlo03dh8Ph9sHWKD4v6hAbD51YLJQSmhuhuMrKpLCm9PF5YfO8CtCPcVPlBRdGJ76lSGymdMqpSbUuUoXg4gGsudrZR0AYcttQWqjcclaJXFfaKprYlFZpYnsqgjftlMqzhrtDNizNqcTBlN1gRvA6zHgnpuanmPGWZ_Jo8lbuTwfTDzv7W_JjBC9bk5DeD_FwRTnrB1c2kbMPXnkEDxsT6Z7mIW4Pz68jyFeMpxNAju_VO252Eri-acaoVzqCNNjGX_SQ_cG43109_pdOL-Da6GC8K3ffTd4_gevYHrKT6VNYW8yX9pnHYAv9PHjZT5wxKgA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_BJiF44PsjfBoJwVO21Hac5LFaV8ZgVekY7M2yHWerBk5VWgn46_E5S9YCEhI8xjknuvM5_p19-R3Ai1QL7QOrPK4YYzE3ysQqo3mstBaM8zLNQ-W5g5HYO-L7x-nxyl_8DT9Et-GGMyN8r3GCz8pq-4I0VJWBN6iHMTHjl2GTCw9_ERZNLgikEJ8Htj2WxoXgeUvbmNDt9f5ry9ImWvjbnzDn76mTq5A2rEnDG6BabZpUlLOt5UJvmR-_ED3-j7o34fo5YCX9xsNuwSXrbsO1FRrDO_Ddf6Jrj-Pr5VcyxiyZ0pJxm3FHPComu84oH45j3p07IcqVZOKXO4X7FCTQgyzm9ex0asiwKf9Dps5Lkb6bfvHvxnptn0ldNaKlPQlU2ehRd-FouPthZy8-L-kQGw-ceJwrlWthciVUWiaFNaWPzgubZVUAflyYKitEbnTiW4rEpkpTwQzVuqAKocU92HC1sw-AcGS2YaxQmRW8yjNdaatYYimraGJ7KoJX7YjKWcPcIRuOZirRmLIzZgQvw4B3Ymp-hvluWSo_jV7Lw8lg8n7_cEd-jOB56xHSz0I8WlHOeuPKJm72oauI4H7jId3TPMDt4el1BNma73QCyPC9fsdNTwPTN0s580pHQINr_EUP2R8c9Lurh__S6RlcGQ-G8t2b0dtHcBWbQ2oyewwbi_nSPvEAbKGfhjn2EwBXKK8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanoporous+peptide+particles+for+encapsulating+and+releasing+neurotrophic+factors+in+an+animal+model+of+neurodegeneration&rft.jtitle=Advanced+materials+%28Weinheim%29&rft.au=Tan%2C+Justin&rft.au=Wang%2C+Yajun&rft.au=Yip%2C+Xiaopei&rft.au=Glynn%2C+Fergal&rft.date=2012-07-03&rft.issn=1521-4095&rft.eissn=1521-4095&rft.volume=24&rft.issue=25&rft.spage=3362&rft_id=info:doi/10.1002%2Fadma.201200634&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0935-9648&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0935-9648&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0935-9648&client=summon